Belize vs Jordan: Cause of death, by non-communicable diseases, ages 15-59
Belize
42.8%
in 2021
Jordan
42.0%
in 2021
Belize rank
141st
Jordan rank
144th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Belize
- Jordan
How they compare
Belize currently reports 42.8% against 42.0% in Jordan, a difference of 0.8%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Jordan ahead.
Belize ranks 141st and Jordan ranks 144th of 185 countries.
Jordan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.0% | 72.8% | 28.8% | Jordan |
| 2010s | 45.1% | 73.9% | 28.8% | Jordan |
| 2020s | 44.5% | 50.1% | 5.6% | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Belize or Jordan?
- Belize, at 42.8% against 42.0% in Jordan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Belize and Jordan?
- 0.8%, with Belize ahead.
- How many years of comparable data are there for Belize and Jordan?
- 6 years are reported by both, from 2000 to 2021.
- How do Belize and Jordan rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Belize ranks 141st and Jordan ranks 144th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.